GLP-1 supplements, boosters and patches: what the FDA says

No GLP-1 patch or GLP-1 supplement is FDA-approved. Every GLP-1 medicine approved for weight loss is a prescription injection or pill, tested in clinical trials and reviewed by the FDA. Products sold online as “GLP-1 patches” or “GLP-1 supplements” are none of these, and the FDA and the Federal Trade Commission (FTC) have both said where they stand. Here is what the rules say, how to spot a product to skip, and the approved options.

What gets sold as a GLP-1 patch or supplement

GLP-1 stands for glucagon-like peptide-1, a gut hormone. The approved drugs, such as semaglutide and tirzepatide, act on the same receptor, which helps regulate appetite and blood sugar. That name has been borrowed by products sold online: adhesive or “microneedle” skin patches, and capsules, drops or powders sold as supplements.

A name is not an ingredient. A product can put “GLP-1” on the box without containing any GLP-1 drug, and the FDA has not reviewed any of these products as a GLP-1 medicine.

The GLP-1 medicines that are FDA-approved

These are the approved GLP-1 options. None is a patch.

Scroll sideways to see the full table

Sources: each drug’s prescribing information (Wegovy, Zepbound, Foundayo, Saxenda, Ozempic, Mounjaro).

Each needs a prescription from a licensed clinician, and each label carries a boxed warning for thyroid C-cell tumors seen in rodents. If you want to avoid needles, the two pills are the approved route: see our oral GLP-1 rankings and the Foundayo vs Wegovy pill guide.

What the FDA says about GLP-1 patches

In a warning letter dated March 31, 2026, the FDA wrote to a seller on an online marketplace about a patch it sold as the “SMGT-GLT-1 Nano Microneedle Patch” (FDA warning letter). The FDA had reviewed the store in December 2025. According to the letter:

• The listing said the patch contained “a blend of fat-burning ingredients (such as caffeine, green tea extract, or other thermogenic compounds)”.
• The listing promoted it for type 2 diabetes treatment, weight loss and cardiovascular protection, and quoted survey figures above 97%.
• Because it was sold to treat disease and affect the body, the FDA said it is a drug. Because it is not generally recognized as safe and effective for those uses and has no approved application, it is an “unapproved new drug”, and selling it across state lines violates federal law.

A warning letter is the FDA’s notice of violations it has found. The seller had 15 working days to respond, and the FDA warned that failing to fix the problems could lead to seizure or an injunction.

The point for a shopper is simple. A patch that claims to treat diabetes or cause weight loss is a drug in the FDA’s eyes, and no such patch has FDA approval.

What the FDA says about “GLP-1” supplements

The FDA’s rules for dietary supplements explain why a supplement can’t stand in for a GLP-1 medicine (FDA Q&A):

• No approval before sale. The FDA “does not have the authority to approve dietary supplements before they are marketed”, and a firm generally does not have to show the FDA its safety evidence.
• No disease claims. A product sold as a supplement that claims to treat, prevent or cure a disease “meets the definition of a drug”. That is why supplement labels that make health claims must say the product “is not intended to diagnose, treat, cure, or prevent any disease”.
• Supplements are swallowed. The FDA says supplements “must be swallowed”, so “topical or inhaled products are not supplements”. A skin patch is not a dietary supplement.
• Drug ingredients are generally excluded. The supplement definition generally excludes ingredients approved as new drugs, unless they were sold as a supplement or food first.

There is a second risk: hidden drugs. The FDA says many weight-loss products, including supplements, pills and teas, “are likely to be contaminated with dangerous hidden ingredients”, are “sometimes falsely advertised as dietary supplements”, and can lead to hospitalization (FDA). Its list of these products carried 7 notices dated June to September 2026, and the FDA says the list covers “only a small fraction” of contaminated products on the market.

The FDA has also warned companies selling semaglutide, tirzepatide, retatrutide and other GLP-1 drugs falsely labeled “for research purposes” or “not for human consumption” while selling them to consumers with dosing instructions. It urges people not to buy these products, which “are of unknown quality and may be harmful” (FDA).

What a “GLP-1 booster” is

Some supplements are sold as GLP-1 “boosters” or “GLP-1 support”. These don’t claim to contain a GLP-1 drug; they say they support the GLP-1 your own body makes. Pendulum’s GLP-1 Probiotic is one example: a capsule with three bacterial strains that, its maker says, “help you produce more of” your own GLP-1. Its product page, read on October 27, 2026, says those claims are “based on preclinical studies” and that the product is “not intended for weight loss”.

The supplement rules above apply to boosters too. The FDA does not approve them before they are sold, and a booster label can’t claim to treat obesity or type 2 diabetes without the product counting as a drug. No booster has gone through FDA approval, so none carries the clinical-trial results printed on an approved GLP-1 label. If you are looking for a GLP-1 medicine, a booster is not one.

What the FTC says

The FTC polices advertising. Its 2014 “Gut Check” guide for media lists 7 weight-loss claims that experts say can’t be true, covering supplements, over-the-counter drugs and products worn on the body or rubbed into the skin (FTC). Among them are claims that a product:

• Causes weight loss of 2 pounds or more a week for a month or more without diet or exercise.
• Causes substantial weight loss no matter what or how much you eat.
• Causes permanent weight loss even after you stop using it.
• Causes substantial weight loss for all users.
• Causes substantial weight loss by wearing it on the body or rubbing it into the skin.

On the last one the guide is direct: because weight loss is an internal metabolic process, “weight loss claims for patches, creams, lotions, wraps, body belts, earrings, and the like are false.”

How to spot a product to skip

Be wary of any product that:

• Puts “GLP-1”, or a drug brand name, on a patch, capsule, gummy or drop sold without a prescription.
• Claims to treat diabetes, protect the heart or replace a prescription drug.
• Promises weight loss without changes to diet or activity, or for everyone.
• Sells semaglutide or tirzepatide labeled “for research purposes”.
• Offers prices that seem too good to be true. The FDA lists deep discounts as a red flag for telehealth GLP-1 sellers, along with skipping a screening and prescription by a licensed clinician and having no licensed clinician to answer questions.

The approved route, and where compounding fits

The way to a GLP-1 medicine runs through a licensed clinician and a state-licensed pharmacy, which is also what the FDA advises. Our guide to getting a GLP-1 prescription online walks through it, and the GLP-1 provider rankings compare telehealth programs. If cost is the barrier, see GLP-1s without insurance, and for other prescription options, Ozempic alternatives.

Some programs prescribe compounded semaglutide or tirzepatide. These are prescription products from a licensed pharmacy, unlike patches and supplements, but they are not Wegovy or Zepbound and not generics of them, and they aren’t FDA-approved. Our guide to compounded semaglutide’s legal status and safety explains the limits.

Report a problem

If you have a reaction to a patch, supplement or any weight-loss product, tell your clinician. You can also report it to the FDA through MedWatch, which takes reports from patients and consumers, or by calling 1-800-FDA-1088.

The bottom line

There is no FDA-approved GLP-1 patch or GLP-1 supplement. The FDA has called one GLP-1 patch an unapproved new drug, says a patch can’t be a dietary supplement, and treats any supplement that claims to treat disease as a drug. The FTC says weight-loss claims for patches are false. The approved GLP-1 medicines are injections and pills, prescribed by a licensed clinician. Our match tool can point you to programs that prescribe them.